pamidronate has been researched along with leuprolide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Fallon, MA; Finkelstein, JS; Leder, BZ; Lee, ML; Smith, MR | 1 |
| Fallon, MA; Finkelstein, JS; Hayden, DL; Kantoff, PW; McGovern, FJ; Schoenfeld, DA; Smith, MR; Zietman, AL | 1 |
| Dawson-Hughes, B | 1 |
| Fallon, MA; Finkelstein, JS; Kantoff, PW; McGovern, FJ; Schoenfeld, DA; Smith, MR; Zietman, AL | 1 |
3 trial(s) available for pamidronate and leuprolide
| Article | Year |
|---|---|
Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone and Bones; Calcitriol; Calcium; Collagen; Collagen Type I; Diphosphonates; Humans; Hypogonadism; Leuprolide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Osteocalcin; Pamidronate; Peptides; Prostatic Neoplasms; Teriparatide; Time Factors | 2001 |
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Bone Density; Bone Resorption; Diphosphonates; Femur; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Lumbar Vertebrae; Male; Osteocalcin; Osteoporosis; Pamidronate; Pelvic Bones; Prostatic Neoplasms | 2001 |
Changes in body composition during androgen deprivation therapy for prostate cancer.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Body Composition; Delayed-Action Preparations; Diphosphonates; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Hemoglobins; Humans; Leuprolide; Lipoproteins; Male; Middle Aged; Pamidronate; Prostate-Specific Antigen; Prostatic Neoplasms | 2002 |
4 other study(ies) available for pamidronate and leuprolide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Bone loss accompanying medical therapies.
Topics: Administration, Inhalation; Antineoplastic Agents, Hormonal; Bone Density; Bone Resorption; Diphosphonates; Female; Glucocorticoids; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Osteoporosis; Pamidronate; Prostatic Neoplasms; Triamcinolone Acetonide | 2001 |